...BRCA2 mutation showed increased sensitivity in irinotecan. In conclusion, the carryover effects of olaparib to improve a...
...BRCA2 hereditary breast and ovarian cancer syndromes, many other syndromes that are associated with genetic mutations pr...
...BRCA2 mutations is around 80%. Genetically engineered BRCA1-deficient mouse models offer a unique opportunity to study t...
...BRCA2, respond favorably to PARP inhibition and platinum-based chemotherapy. We investigated whether other prostate tumo...
...BRCA2 (BRCA1/2) have been conventionally analyzed by Sanger sequencing and multiplex ligation-dependent probe amplificat...
...BRCA2 genes. The mutation prevalence is variable based on ethnicity and may be influenced by founder mutations. The aim ...
...BRCA2, PALB2, PTCH1, SUFU, TP53, and GPR161. The strongest evidence for association was found for rs201458864 (PALB2, OR...
...BRCA2 (2%). In 31 patients (70%) a TT was recommended. A total of 12/31 patients (39%) received the recommended therapy....
...BRCA2 genes (BRCA mutations). Little is known, however, about any correlation between the deletion size and location of ...
...BRCA2 testing showed good analytical performance and a short hands-on time. Because of its integrated sample preparation...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
